These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9433493)

  • 1. The role of reactive-center loop mobility in the serpin inhibitory mechanism.
    Lawrence DA
    Adv Exp Med Biol; 1997; 425():99-108. PubMed ID: 9433493
    [No Abstract]   [Full Text] [Related]  

  • 2. Serpins. A mechanistic class of their own.
    Stone SR; Whisstock JC; Bottomley SP; Hopkins PC
    Adv Exp Med Biol; 1997; 425():5-15. PubMed ID: 9433485
    [No Abstract]   [Full Text] [Related]  

  • 3. Modeling of serpin-protease complexes: antithrombin-thrombin, alpha 1-antitrypsin (358Met-->Arg)-thrombin, alpha 1-antitrypsin (358Met-->Arg)-trypsin, and antitrypsin-elastase.
    Whisstock J; Lesk AM; Carrell R
    Proteins; 1996 Nov; 26(3):288-303. PubMed ID: 8953650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serpin-proteinase complex revealed.
    Lawrence DA
    Nat Struct Biol; 1997 May; 4(5):339-41. PubMed ID: 9145100
    [No Abstract]   [Full Text] [Related]  

  • 5. A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate-binding pocket and oxyanion hole in the serpin inhibitory mechanism.
    Egelund R; Petersen TE; Andreasen PA
    Eur J Biochem; 2001 Feb; 268(3):673-85. PubMed ID: 11168406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for serpin inhibitor activity.
    Wright HT; Scarsdale JN
    Proteins; 1995 Jul; 22(3):210-25. PubMed ID: 7479695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serine and cysteine proteases are translocated to similar extents upon formation of covalent complexes with serpins. Fluorescence perturbation and fluorescence resonance energy transfer mapping of the protease binding site in CrmA complexes with granzyme B and caspase-1.
    Swanson R; Raghavendra MP; Zhang W; Froelich C; Gettins PG; Olson ST
    J Biol Chem; 2007 Jan; 282(4):2305-13. PubMed ID: 17142451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity and reactive loop length requirements for crmA inhibition of serine proteases.
    Tesch LD; Raghavendra MP; Bedsted-Faarvang T; Gettins PG; Olson ST
    Protein Sci; 2005 Feb; 14(2):533-42. PubMed ID: 15632287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reactive site loop of the serpin SCCA1 is essential for cysteine proteinase inhibition.
    Schick C; Brömme D; Bartuski AJ; Uemura Y; Schechter NM; Silverman GA
    Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13465-70. PubMed ID: 9811823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions.
    Schreuder HA; de Boer B; Dijkema R; Mulders J; Theunissen HJ; Grootenhuis PD; Hol WG
    Nat Struct Biol; 1994 Jan; 1(1):48-54. PubMed ID: 7656006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the specificity of serpin-protease complexes through interface analysis.
    Rashid Q; Kapil C; Singh P; Kumari V; Jairajpuri MA
    J Biomol Struct Dyn; 2015; 33(6):1352-62. PubMed ID: 25052369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What do dysfunctional serpins tell us about molecular mobility and disease?
    Stein PE; Carrell RW
    Nat Struct Biol; 1995 Feb; 2(2):96-113. PubMed ID: 7749926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serpins: the uncut version.
    Goldsmith EJ; Mottonen J
    Structure; 1994 Apr; 2(4):241-4. PubMed ID: 8087550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory mechanism of serpins. Identification of steps involving the active-site serine residue of the protease.
    Stone SR; Le Bonniec BF
    J Mol Biol; 1997 Jan; 265(3):344-62. PubMed ID: 9018048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insight into the mechanism of serpin-proteinase inhibition from 2D [1H-15N] NMR studies of the 69 kDa alpha 1-proteinase inhibitor Pittsburgh-trypsin covalent complex.
    Peterson FC; Gettins PG
    Biochemistry; 2001 May; 40(21):6284-92. PubMed ID: 11371190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, antithrombin III, alpha 2-antiplasmin, angiotensinogen, and ovalbumin.
    Mast AE; Enghild JJ; Pizzo SV; Salvesen G
    Biochemistry; 1991 Feb; 30(6):1723-30. PubMed ID: 1704258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of secondary structure predictions on the reactive center loop region of serpins: a model for the folding of serpins into a metastable state.
    Patston PA; Gettins PG
    FEBS Lett; 1996 Mar; 383(1-2):87-92. PubMed ID: 8612799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into serpin-protease complexes reveal the inhibitory mechanism of serpins.
    Wilczynska M; Fa M; Karolin J; Ohlsson PI; Johansson LB; Ny T
    Nat Struct Biol; 1997 May; 4(5):354-7. PubMed ID: 9145103
    [No Abstract]   [Full Text] [Related]  

  • 19. Crystal structure of viral serpin crmA provides insights into its mechanism of cysteine proteinase inhibition.
    Simonovic M; Gettins PGW ; Volz K
    Protein Sci; 2000 Aug; 9(8):1423-7. PubMed ID: 10975564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombin. A bloody important serpin.
    Björk I; Olson ST
    Adv Exp Med Biol; 1997; 425():17-33. PubMed ID: 9433486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.